Pro Dex PDEX
NASDAQ PDEX
$65.66 -1.76 (-2.61%)
At close: Nov 13, 2026 · 4:00 PM EST

Pro Dex (PDEX) Net Income towards Common Stockholders (2009 - 2026)

Updated

Pro Dex's Net Income towards Common Stockholders came in at $3.05 million for fiscal Q1 2027 (quarter ended Sep 30, 2026), down 34.9% from $4.68 million a year earlier but up 6.7% from the prior quarter.

Analysis

Pro Dex (PDEX) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Pro Dex reported Net Income towards Common Stockholders of $12.03 million, up 7.5% year-over-year; for FY2026 (ended Jun 30, 2026), it came in at $13.66 million, up 52.2% from FY2025.

  • Net Income towards Common Stockholders carries a five-year compound annual growth rate of 17.2% (FY2021 to FY2026).
  • Going back by fiscal year, Net Income towards Common Stockholders was $8.98 million in FY2025 (+322.1%), $2.13 million in FY2024 (-69.9%), $7.07 million in FY2023 (+54.7%) and $4.57 million in FY2022 (-25.9%).
  • The five-year range for quarterly Net Income towards Common Stockholders is -$615,000 (fiscal Q1 2024) to $4.68 million (fiscal Q1 2026).
  • Year-over-year, Net Income towards Common Stockholders increased in six of the last eight quarters, with growth averaging 113.1%.
  • The fastest year-over-year change in Net Income towards Common Stockholders over five years came in fiscal Q3 2025 (growth of 400.0%), and the weakest in fiscal Q2 2024 (a decline of 81.8%).
  • Business Quant data shows PDEX's Net Income towards Common Stockholders at $2.86 million (Q4 2026), $3.94 million (Q3 2026) and $2.19 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 1.72 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn 920.00 Mn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn 1.24 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn 522.80 Mn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 1.47 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn 753.00 Mn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 582.00 Mn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 301.40 Mn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 321.00 Mn
10 Pro Dex 210.33 Mn 174.25 Mn 6.86 Mn 3.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.05 Mn
Jun 30, 2026 2.86 Mn
Mar 31, 2026 3.94 Mn
Dec 31, 2025 2.19 Mn
Sep 30, 2025 4.68 Mn
Jun 30, 2025 1.20 Mn
Mar 31, 2025 3.28 Mn
Dec 31, 2024 2.04 Mn
Sep 30, 2024 2.47 Mn
Jun 30, 2024 1.59 Mn
Mar 31, 2024 655,000.00
Dec 31, 2023 500,000.00
Sep 30, 2023 -615,000.00
Jun 30, 2023 1.50 Mn
Mar 31, 2023 1.62 Mn
Dec 31, 2022 2.75 Mn
Sep 30, 2022 1.20 Mn
Jun 30, 2022 1.84 Mn
Mar 31, 2022 462,000.00
Dec 31, 2021 925,000.00
API Access

Pro Dex Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=PDEX&period=max&api_key=YOUR_API_KEY